Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ADCIRCA (tadalafil)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ADCIRCA (tadalafil)

Medicine - Posted on Jan 05 2011 - Updated on Jun 12 2019
Active substance (DCI)
  • tadalafil
history (2)
  • 1/5/11

    ADCIRCA

    Progrès thérapeutique : – important pour FLOLAN ; – modéré pour TRACLEER ; – mineur pour ADCIRCA, REMODULIN, REVATIO, VENTAV...
    CAV :
    54321
    icône flèche
  • 7/21/10

    ADCIRCA (tadalafil)

    Pas d’avantage clinique démontré par rapport aux autres traitements de l'hypertension artérielle pulmonaire ADCIRCA est indi...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • G04BE08
Manufacturer
Laboratoire LILLY FRANCE
Presentation

ADCIRCA 20 mg, comprimé pelliculé - Boîte de 28 - Code CIP : 3471527 / Boîte de 56 - Code CIP : 3471533

All our publications
    Drug therapy Pulmonary and pleural diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
DYnwGXwfqV39Lrny